AzTrials
AzTrials

Cervical Intraepithelial NeoplasiasNCT06695871

Research on the Application of Patient Navigation-based Management Model of Patients After LEEP

A study testing Patient navigation-based health management in people with Cervical Intraepithelial Neoplasias, run by Peking University People's Hospital at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Cervical cancer poses a significant threat to women's health and is a crucial public health issue. Early detection and treatment of cervical lesions and standardized management have emerged as essential pillars in the Global Cervical Cancer Elimination. Read more about this study

Who is it for?
Ages 25 to 50 years, women only
Conditions the study is for
Cervical Intraepithelial Neoplasias
What is being tested?
Patient navigation-based health management
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteChina
Study dates
1 Dec 2024to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Individuals aged between 25 and 50 years;
  • LEEP will be conducted following clinical evaluation;
  • No intention to conceive within the subsequent year;
  • Proficiency in utilizing social media platforms, such as WeChat, is required;
  • Patients must be capable of providing informed consent to participate in the study and willing to engage in long-term follow-up.

Who cannot join

  • Individuals who are widowed, separated, or experiencing atypical sexual activity due to reasons related to their spouse.
  • Presence of genital tract malformations.
  • A history of neurological disorders, such as stroke or epilepsy, or a history of psychiatric conditions, such as depression.
  • Patients with other significant illnesses that could impact the long-term follow-up of the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Wenhui Ren, PhD contact

86+18800124938

rwh0617@outlook.com

China1 site
  • Peking University People's Hospital

    Beijing, Beijing Municipality, 100044

    Wenhui Ren, PhD, 86+18800124938, rwh0617@outlook.com

Other trials in China

About this study

Official title: Effect of Patient Navigation-based Health Management Model on Quality of Life and Sexual Function After LEEP in Patients With Cervical Lesions

Cervical cancer poses a significant threat to women's health and is a crucial public health issue. Early detection and treatment of cervical lesions and standardized management have emerged as essential pillars in the Global Cervical Cancer Elimination. The loop electrosurgical excision procedure (LEEP) is widely employed as a preferred approach for the diagnosis and treatment of precancerous cervical lesions and early invasive cervical cancer. Patients with high-grade cervical lesions are more prone to experiencing sexual dysfunction and psychological disorders after LEEP, attributed to the unique surgical site, physiological alterations, and psychological stress during the postoperative recovery process, thereby adversely affecting their quality of life. Currently, there is a shortage of research evidence regarding targeted intervention measures and long-term effect evaluations for sexual function quality and quality of life after LEEP for cervical lesions. In recent years, the health management model based on patient navigation has evolved into a novel modality for facilitating comprehensive tumor prevention and control. However, its effect in managing cervical lesions has yet to be comprehensively assessed. Therefore, we will design a randomized controlled trial to evaluate the impact of a patient navigation-based health management model on quality of life and sexual function after LEEP in patients with cervical lesions.

Being tested
Patient navigation-based health management
Keywords
Loop electrosurgical excision procedure, Patient navigation, Quality of life, Sexual function

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patient navigation-based health managementOther

    A patient navigation-based health management model for individuals with cervical lesions post-LEEP procedure, encompassing healthcare consultation services, personalized health guidance, and routine follow-up assessments.

Study groups in NCT06695871
Study groupRoleWhat they receive
Control groupNo interventionThe routine clinical outpatient follow-up protocol was implemented, and a postoperative rehabilitation health manual was provided to patients the day following LEEP surgery. Outpatient evaluations were subsequently conducted at 1 month, 3 months, and 6 months post-surgery.
Intervention groupExperimentalA postoperative rehabilitation health manual was provided to patients the day following LEEP surgery. The nursing team, possessing over one year of clinical experience in gynecological nursing and psychological counseling, collaborated with clinicians to deliver health consultation services. They conducted in-person consultations lasting 10-15 minutes during routine outpatient follow-ups at 1, 3, and 6 months post-surgery. Patients were assessed based on the challenges encountered in postoperative rehabilitation and sexual life, and tailored guidance services were administered. Additionally, online counseling and guidance services were offered at 2, 4, or 5 months following surgery.
Receives: Other: Patient navigation-based health management

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of Life

    The quality of life six months post-surgery was assessed using 36-Item Short Form Survey.

    Measured: six months after LEEP

Secondary outcomes (6)
  1. Sexual function index

    The Chinese version of the Female Sexual Function Index was used to evaluate the sexual function index at three time points: before LEEP, three months after LEEP, and six months after LEEP.

    Measured: before LEEP, three months after LEEP, and six months after LEEP

  2. Anxiety

    Anxiety symptoms were assessed using the Self-Rating Anxiety Scale at three-time points: before LEEP, three months after LEEP, and six months after LEEP.

    Measured: before LEEP, three months after LEEP, and six months after LEEP

  3. Quality of Life

    The quality of life was assessed using 36-Item Short Form Survey.

    Measured: before LEEP and three months after LEEP

  4. Depression

    Depression symptoms were assessed using the Self-Rating Anxiety Scale at three time points: before LEEP, three months after LEEP, and six months after LEEP.

    Measured: before LEEP, three months after LEEP, and six months after LEEP

  5. Vaginal discharge

    Patient-reported alterations in the volume, color, and odor of vaginal secretions.

    Measured: three and six months after LEEP

  6. Recurrence rates

    The recurrence of cervical lesions at three and six months post-surgery was evaluated using high-risk HPV testing, cytology test, and histopathological examination.

    Measured: three and six months after LEEP

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2024
  2. Study start1 Dec 2024 (estimated)
  3. Primary completion1 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06695871
Sponsor's protocol ID
2024PHB398-001
Other IDs
MBZX0102024007
Status last verified
Nov 2024
First submitted
16 Nov 2024
Last updated
19 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Patient navigation-based health management in people with Cervical Intraepithelial Neoplasias, run by Peking University People's Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 19 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Wenhui Ren, PhD (86+18800124938, rwh0617@outlook.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of Life (time frame: six months after LEEP). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in